Key points are not available for this paper at this time.
New ACC–AHA guidelines represent a substantial departure from previous recommendations for lipid management and may have a major effect on clinical practice. Overall, they will move treatment toward statins and deemphasize other agents for a broader range of patients.
Keaney et al. (Wed,) studied this question.